LUNAC Therapeutics

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.

TargED

This biotechnology company develops targeted biological drugs that deliver enzymes to blood clots to treat patients with various forms of thrombosis.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

City Therapeutics

This biotechnology company develops next-generation RNA interference therapeutics for patients with thromboembolic diseases, retinal disorders, and anaemia.

LaNua Medical

This company develops embolisation devices that block blood flow in vessels to treat tumours and internal bleeding for radiologists and surgeons.